Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability.
about
Genetic Testing for Opioid Pain Management: A PrimerClinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeCYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.Pharmacogenomic considerations in opioid analgesia.Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteersCore outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsThe relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users.
P2860
Q33736174-FB965A1C-485F-4E38-BFC8-589E162D0221Q34243414-26DAF18C-E2F1-4347-AC85-0293CE843A05Q34302849-9D6AA9F9-D25A-440C-8EE9-4954C7B2D4EAQ34316700-2A213B32-108B-4D54-8CDD-002F68EF914EQ34399802-A98948CC-1D0D-4F07-B1F8-9C95E1C5256AQ35017701-515E5535-F869-4C5A-8EC0-E95A4711D753Q36389047-2E77F361-4015-40A9-96E2-B6CD88988A98Q37156564-8FF2479F-E5B8-4BE1-BCDC-B3247BB223B7Q37616572-CA4020F5-985E-4AC5-B0AC-52A8DB80DFC9
P2860
Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@ast
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@en
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@nl
type
label
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@ast
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@en
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@nl
prefLabel
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@ast
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@en
Inhibition of cytochrome P450 ...... tantly affect abuse liability.
@nl
P2093
P1476
Inhibition of cytochrome P450 ...... rtantly affect abuse liability
@en
P2093
Sellers EM
P304
P407
P577
1997-04-01T00:00:00Z